🇺🇸 FDA
Pipeline program

Cytokine-induced killer cells+ FOLFOX4

CIK-2

Approved small_molecule completed

Quick answer

Cytokine-induced killer cells+ FOLFOX4 for Colorectal Cancer is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Colorectal Cancer
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials